Literature DB >> 20121738

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

B Sis1, M Mengel, M Haas, R B Colvin, P F Halloran, L C Racusen, K Solez, W M Baldwin, E R Bracamonte, V Broecker, F Cosio, A J Demetris, C Drachenberg, G Einecke, J Gloor, D Glotz, E Kraus, C Legendre, H Liapis, R B Mannon, B J Nankivell, V Nickeleit, J C Papadimitriou, P Randhawa, H Regele, K Renaudin, E R Rodriguez, D Seron, S Seshan, M Suthanthiran, B A Wasowska, A Zachary, A Zeevi.   

Abstract

The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121738     DOI: 10.1111/j.1600-6143.2009.02987.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  180 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.

Authors:  W Wong; J DeVito; H Nguyen; D Sarracino; F Porcheray; I Dargon; P D Pelle; A B Collins; N Tolkoff-Rubin; R N Smith; R Colvin; E Zorn
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

Review 3.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

4.  Banff 2011 Meeting report: new concepts in antibody-mediated rejection.

Authors:  M Mengel; B Sis; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; L Cendales; A J Demetris; C B Drachenberg; C F Farver; E R Rodriguez; W D Wallace; D Glotz
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

5.  Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Authors:  Melissa Krystel-Whittemore; Ellen T McCarthy; Ivan Damjanov; Timothy A Fields
Journal:  BMJ Case Rep       Date:  2015-08-28

6.  Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique.

Authors:  Vincent Vuiblet; Michael Fere; Cyril Gobinet; Philippe Birembaut; Olivier Piot; Philippe Rieu
Journal:  J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 10.121

7.  Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

Authors:  K M Dwyer; D Hanidziar; P Putheti; P A Hill; S Pommey; J L McRae; A Winterhalter; G Doherty; S Deaglio; M Koulmanda; W Gao; S C Robson; T B Strom
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

8.  Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Authors:  Julio Pascual; Stefan P Berger; Oliver Witzke; Helio Tedesco; Shamkant Mulgaonkar; Yasir Qazi; Steven Chadban; Federico Oppenheimer; Claudia Sommerer; Rainer Oberbauer; Yoshihiko Watarai; Christophe Legendre; Franco Citterio; Mitchell Henry; Titte R Srinivas; Wen-Lin Luo; AnaMaria Marti; Peter Bernhardt; Flavio Vincenti
Journal:  J Am Soc Nephrol       Date:  2018-05-11       Impact factor: 10.121

Review 9.  Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.

Authors:  David F Pinelli; Mandy L Ford
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

10.  Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.

Authors:  B Adam; P Randhawa; S Chan; G Zeng; H Regele; Y B Kushner; R B Colvin; J Reeve; M Mengel
Journal:  Am J Transplant       Date:  2014-08-04       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.